Updated:
KHAO KLA Venture Capital Management
KHAO KLA Venture Capital Management is a private equity firm based in Bangkok, Thailand. It focuses on venture capital investments. The firm has a team of four...
KHAO KLA Venture Capital Management
KHAO KLA Venture Capital Management is a private equity firm based in Bangkok, Thailand. It focuses on venture capital investments. The firm has a team of four staff, including four investment professionals.
General information
Firm type
Venture Capital
Year founded
2007
AUM
Undisclosed
Location
Region
Asia
Country
Thailand
City
Bangkok
Corporate office
Bangkok, Thailand
Principals
Krating Poonpol
Chairman
Thanapong Na Ranong
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at KHAO KLA?
Chairman Krating Poonpol sets the firm's investment thesis and macro strategy, drawing on his prior experience at UBS and 500 Startups. Day-to-day deal execution and portfolio management are led by Managing Director Thanapong Na Ranong. The partnership committee — comprising Poonpol, Na Ranong and select senior investment professionals — holds final authority on commitments above the seed stage.
How does KHAO KLA source proprietary deal flow?
The firm's pipeline draws from three channels: a partnership with Kasikornbank (Thailand's second-largest commercial bank), which surfaces fintech and enterprise leads from its corporate client base; an in-house scouting network across Thai university incubators, particularly Chulalongkorn University; and the personal networks of chairman Krating Poonpol, a visible figure in Thailand's startup ecosystem. This local embeddedness allows KHAO KLA to meet founders before international multi-stage funds arrive.
Is KHAO KLA a single-family office or an independent venture firm?
KHAO KLA is structured as an independent venture capital management company, not a family office. Its limited partners include Thai institutional investors — commercial banks, insurance companies and corporate venture arms — alongside Beacon VC, the venture capital arm of Kasikornbank. Chairman Krating Poonpol is a professional investor and former banker with no disclosed family-office affiliation.
Does KHAO KLA participate in fund commitments or only direct deals?
KHAO KLA primarily makes direct equity and convertible-note investments into startups at pre-seed, seed and Series A stages. The firm also manages co-branded fund vehicles — notably the Beacon Impact Fund, a joint initiative with Kasikornbank's Beacon Venture Capital — where it serves as co-manager alongside a corporate LP. KHAO KLA does not position itself as a fund-of-funds allocator; any fund-level commitments are incidental to its partnership architecture.
What investment stages does KHAO KLA typically target?
KHAO KLA covers the pre-seed through Series A spectrum. Seed and pre-seed — typically ticket sizes ranging from $100,000 to $750,000 — remain its core volume driver. The firm reserves follow-on capacity for select Series A and bridge rounds within its existing portfolio. Later-stage checks are rare and typically routed through co-investment structures alongside Beacon VC rather than KHAO KLA's own vehicles.
How is KHAO KLA related to Beacon Venture Capital and Kasikornbank?
Beacon VC operates as the corporate venture capital unit of Kasikornbank, one of Thailand's largest commercial banks. KHAO KLA and Beacon VC maintain a strategic co-management relationship: the two firms jointly manage the Beacon Impact Fund, targeting sustainability-linked technology startups in Thailand, Vietnam and Indonesia. KHAO KLA remains operationally independent and is not a subsidiary of Kasikornbank, though the partnership creates a commercial distribution channel for portfolio companies through the bank's client base.
Which sectors does KHAO KLA explicitly avoid?
KHAO KLA's public investment mandate omits sectors that require heavy capital expenditure or regulated infrastructure, such as heavy industrials, oil and gas, and hard-asset real estate development. The firm has not disclosed positions in defense technology, consumer packaged goods, or biotechnology requiring FDA-equivalent clinical-trial pathways. Its focus remains on capital-efficient software and platform businesses that scale without large physical-asset deployment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: